Januvia Among 7 Product Adaptations Approved In Japan
This article was originally published in PharmAsia News
Executive Summary
Japan announced the approval of additional adaptations for existing drugs on May 23, including Januvia tablets (sitagliptin phosphate hydrate) from MSD and Glactiv tablets (sitagliptin phosphate hydrate) from Shionogi for Type 2 diabetes treatment as were Takeda’s Nesina tablets (alogliptin benzoate).